References
- Love P E, Santoro S A. Antiphospholipid antibodies: anti-cardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 682–98
- Hughes G RV, Harris E N, Gharavi A E. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486–9
- Lubbe W F, Butler W S, Palmer S J, et al. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983; i: 1361–3
- Elder M G, de Swiet M, Robertson A, et al. Low-dose aspirin in pregnancy. Lancet 1988; i: 410, (letter)
- Rosove M H, Tabsh K, Wassertrum N, et al. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75: 630–4
- Can-Eras L O, Perez G N, Vega H R, Casavilla F. Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 1988; 2: 393–4, (letter)
- MacLachlan N A, Letsky E, DeSwiet M, Rodeck C H. The use of intravenous immunoglobulin therapy in the management of antiphospholipid antibody associated pregnancies. Clin Exp Rheumatol 1990; 8: 221
- Lockshin M D, Druzin M L, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989; 160: 439–43
- Wapner R J, Cowchock F S, Shapiro S S. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol 1989; 161: 1271–2
- Vaarala O, Vaara M, Palosuo T. Effective inhibition of cardiolipin-binding antibodies in Gram-negative infections by bacterial lipopolysaccharide. Scand J Immunol 1988; 28: 607–12
- Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987; 57: 144–7
- Norberg R, Nived O, Sturfelt G, Unander M, Årfors L. Anticardiolipin and complement activation: relation to clinical symptoms. J Rehumatol 1987; 14: 149–53
- Branch D W, Scott J R, Kochenour N K, Hershgold E. Obstetric complications associated with lupus anticoagulant. N Engl J Med 1985; 313: 1322–6
- Reece E A, Gabrielli S, CuUen M T, et al. Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am J Obstet Gynecol 1990; 163: 162–9
- Parke A, Maier D, Hakim C, et al. Subclinical autoimmune disease and recurrent spontaneous abortion. J Rheumatol 1986; 13: 1178
- Webster A DB. Intravenous immunoglobulins. BMJ (editorial) 1991; 303: 375–6